AML-Targeted Nanomedicines

Reverses Resistance Safely

Through ligand conjugation, biomimetic nanotechnology, and bone marrow targeting, these nanomedicines overcome the high toxicity and drug resistance of conventional chemotherapy, offering clinically translatable delivery systems for refractory leukemia.

Wu, Xia · Wang, Fangfang · Gong, Yuping · Niu, Ting · Chu, Bingyang · Ying, Qu · Qian, Zhiyong

Small 2024